Risk of stroke in hospitalized SARS-CoV-2 infected patients: A multinational study.
COVID-19
Cerebrovascular disorders
Intracranial haemorrhage
Neurological complications
SARS-CoV-2
Stroke
Venous thrombosis
Journal
EBioMedicine
ISSN: 2352-3964
Titre abrégé: EBioMedicine
Pays: Netherlands
ID NLM: 101647039
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
15
06
2020
revised:
04
07
2020
accepted:
20
07
2020
pubmed:
21
8
2020
medline:
2
10
2020
entrez:
21
8
2020
Statut:
ppublish
Résumé
There is an increased attention to stroke following SARS-CoV-2. The goal of this study was to better depict the short-term risk of stroke and its associated factors among SARS-CoV-2 hospitalized patients. This multicentre, multinational observational study includes hospitalized SARS-CoV-2 patients from North and South America (United States, Canada, and Brazil), Europe (Greece, Italy, Finland, and Turkey), Asia (Lebanon, Iran, and India), and Oceania (New Zealand). The outcome was the risk of subsequent stroke. Centres were included by non-probability sampling. The counts and clinical characteristics including laboratory findings and imaging of the patients with and without a subsequent stroke were recorded according to a predefined protocol. Quality, risk of bias, and heterogeneity assessments were conducted according to ROBINS-E and Cochrane Q-test. The risk of subsequent stroke was estimated through meta-analyses with random effect models. Bivariate logistic regression was used to determine the parameters with predictive outcome value. The study was reported according to the STROBE, MOOSE, and EQUATOR guidelines. We received data from 26,175 hospitalized SARS-CoV-2 patients from 99 tertiary centres in 65 regions of 11 countries until May 1st, 2020. A total of 17,799 patients were included in meta-analyses. Among them, 156(0.9%) patients had a stroke-123(79%) ischaemic stroke, 27(17%) intracerebral/subarachnoid hemorrhage, and 6(4%) cerebral sinus thrombosis. Subsequent stroke risks calculated with meta-analyses, under low to moderate heterogeneity, were 0.5% among all centres in all countries, and 0.7% among countries with higher health expenditures. The need for mechanical ventilation (OR: 1.9, 95% CI:1.1-3.5, p = 0.03) and the presence of ischaemic heart disease (OR: 2.5, 95% CI:1.4-4.7, p = 0.006) were predictive of stroke. The results of this multi-national study on hospitalized patients with SARS-CoV-2 infection indicated an overall stroke risk of 0.5%(pooled risk: 0.9%). The need for mechanical ventilation and the history of ischaemic heart disease are the independent predictors of stroke among SARS-CoV-2 patients. None.
Sections du résumé
BACKGROUND
BACKGROUND
There is an increased attention to stroke following SARS-CoV-2. The goal of this study was to better depict the short-term risk of stroke and its associated factors among SARS-CoV-2 hospitalized patients.
METHODS
METHODS
This multicentre, multinational observational study includes hospitalized SARS-CoV-2 patients from North and South America (United States, Canada, and Brazil), Europe (Greece, Italy, Finland, and Turkey), Asia (Lebanon, Iran, and India), and Oceania (New Zealand). The outcome was the risk of subsequent stroke. Centres were included by non-probability sampling. The counts and clinical characteristics including laboratory findings and imaging of the patients with and without a subsequent stroke were recorded according to a predefined protocol. Quality, risk of bias, and heterogeneity assessments were conducted according to ROBINS-E and Cochrane Q-test. The risk of subsequent stroke was estimated through meta-analyses with random effect models. Bivariate logistic regression was used to determine the parameters with predictive outcome value. The study was reported according to the STROBE, MOOSE, and EQUATOR guidelines.
FINDINGS
RESULTS
We received data from 26,175 hospitalized SARS-CoV-2 patients from 99 tertiary centres in 65 regions of 11 countries until May 1st, 2020. A total of 17,799 patients were included in meta-analyses. Among them, 156(0.9%) patients had a stroke-123(79%) ischaemic stroke, 27(17%) intracerebral/subarachnoid hemorrhage, and 6(4%) cerebral sinus thrombosis. Subsequent stroke risks calculated with meta-analyses, under low to moderate heterogeneity, were 0.5% among all centres in all countries, and 0.7% among countries with higher health expenditures. The need for mechanical ventilation (OR: 1.9, 95% CI:1.1-3.5, p = 0.03) and the presence of ischaemic heart disease (OR: 2.5, 95% CI:1.4-4.7, p = 0.006) were predictive of stroke.
INTERPRETATION
CONCLUSIONS
The results of this multi-national study on hospitalized patients with SARS-CoV-2 infection indicated an overall stroke risk of 0.5%(pooled risk: 0.9%). The need for mechanical ventilation and the history of ischaemic heart disease are the independent predictors of stroke among SARS-CoV-2 patients.
FUNDING
BACKGROUND
None.
Identifiants
pubmed: 32818804
pii: S2352-3964(20)30315-7
doi: 10.1016/j.ebiom.2020.102939
pmc: PMC7429203
pii:
doi:
Types de publication
Journal Article
Meta-Analysis
Langues
eng
Sous-ensembles de citation
IM
Pagination
102939Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.
Références
Stroke. 2011 Feb;42(2):359-66
pubmed: 21193752
Age Ageing. 2009 Jan;38(1):100-3
pubmed: 19029068
Clin Med (Lond). 2020 Mar;20(2):124-127
pubmed: 32139372
J Neurol Sci. 2018 Mar 15;386:12-18
pubmed: 29406959
Intensive Care Med. 2020 Jun;46(6):1089-1098
pubmed: 32367170
JAMA. 2011 Nov 23;306(20):2248-54
pubmed: 22081378
Cerebrovasc Dis. 2008;26(6):630-5
pubmed: 18984948
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131
J Clin Invest. 2020 May 1;130(5):2620-2629
pubmed: 32217835
Neurohospitalist. 2015 Jul;5(3):173-81
pubmed: 26288675
J Med Virol. 2020 Jun;92(6):552-555
pubmed: 32104915
J Clin Epidemiol. 2015 Aug;68(8):860-9
pubmed: 25959635
Case Rep Neurol Med. 2016;2016:3502683
pubmed: 27239356
Stroke. 2005 Apr;36(4):757-61
pubmed: 15746460
Minerva Anestesiol. 2009 May;75(5):245-50
pubmed: 18636061
J Thromb Haemost. 2020 Jun;18(6):1421-1424
pubmed: 32271988
N Engl J Med. 2020 Feb 27;382(9):872-874
pubmed: 31991079
Pract Neurol. 2014 Feb;14(1):23-31
pubmed: 24453269
Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261
pubmed: 32253535
J Thromb Haemost. 2020 Jul;18(7):1747-1751
pubmed: 32302448
Stroke. 2017 Mar;48(3):574-580
pubmed: 28196938
Stroke Vasc Neurol. 2020 Sep;5(3):279-284
pubmed: 32616524
J Neurol Neurosurg Psychiatry. 2020 Aug;91(8):889-891
pubmed: 32354768
N Engl J Med. 2004 Dec 16;351(25):2611-8
pubmed: 15602021
Saudi Med J. 2017 Feb;38(2):196-200
pubmed: 28133694
N Engl J Med. 2020 Jun 11;382(24):2372-2374
pubmed: 32302078
Blood. 2020 Jun 4;135(23):2033-2040
pubmed: 32339221
Ann Clin Transl Neurol. 2018 Mar 14;5(4):456-463
pubmed: 29687022
Pediatr Rep. 2011 Sep 30;3(4):e30
pubmed: 22355515
Ann Transl Med. 2018 Aug;6(16):318
pubmed: 30363955
Thromb Haemost. 2012 Dec;108(6):1089-96
pubmed: 23093373
Eur J Radiol. 2020 May;126:108961
pubmed: 32229322
Curr Opin Anaesthesiol. 2015 Apr;28(2):227-36
pubmed: 25590467
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
J Renin Angiotensin Aldosterone Syst. 2016 Aug 03;17(3):
pubmed: 27488276
Crit Care Med. 2017 May;45(5):790-797
pubmed: 28296811
Acta Biomed. 2020 Mar 19;91(1):157-160
pubmed: 32191675
eNeurologicalSci. 2019 May 16;15:100193
pubmed: 31193470
Brain Behav Immun. 2020 Jul;87:18-22
pubmed: 32240762
Infection. 2015 Aug;43(4):495-501
pubmed: 25600929
BMJ. 2008 Jul 08;337:a718
pubmed: 18614488
Thromb Res. 2020 Jul;191:145-147
pubmed: 32291094
Stroke. 2013 Jul;44(7):2064-89
pubmed: 23652265
Ann Intern Med. 2013 Feb 19;158(4):280-6
pubmed: 23420236
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
Stroke. 2019 May;50(5):1046-1051
pubmed: 30896327
N Engl J Med. 2020 Apr 23;382(17):e38
pubmed: 32268022
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
J Neurol. 2009 Apr;256(4):591-9
pubmed: 19444533
Circ Res. 2013 Oct 12;113(9):1087-1096
pubmed: 24014829
Acta Neurol Taiwan. 2005 Sep;14(3):113-9
pubmed: 16252612
Acta Physiol (Oxf). 2020 Jul;229(3):e13473
pubmed: 32223077
N Engl J Med. 2020 May 14;382(20):e60
pubmed: 32343504
JAMA Neurol. 2020 Jun 1;77(6):683-690
pubmed: 32275288
Cardiology. 2009;113(2):98-107
pubmed: 19018144